# Artisan Partners Asset Management Inc.: financial statements, quarterly

APAM · NYSE · CIK 1517302 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apam.md) · [Financials](/companies/apam/financials.md) · [Filings](/companies/apam/filings.md) · [Insiders](/companies/apam/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apam/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [249 d](/filings/0001517302-26-000047.md) | [264](/filings/0001517302-25-000042.md) | [271](/filings/0001517302-25-000068.md) | [280](/filings/0001517302-25-000086.md) | [297 d](/filings/0001517302-26-000047.md) | [277](/filings/0001517302-26-000091.md) | [283](/filings/0001517302-25-000068.md) | [301](/filings/0001517302-26-000133.md) | [336 d](/filings/0001517302-26-000047.md) | [303](/filings/0001517302-26-000091.md) | [308](/filings/0001517302-26-000114.md) | [313](/filings/0001517302-26-000133.md) |
| Operating income | $m | [76.4 d](/filings/0001517302-26-000047.md) | [77.6](/filings/0001517302-25-000042.md) | [86.6](/filings/0001517302-25-000068.md) | [93.2](/filings/0001517302-25-000086.md) | [109 d](/filings/0001517302-26-000047.md) | [86.5](/filings/0001517302-26-000091.md) | [79.8](/filings/0001517302-26-000114.md) | [102](/filings/0001517302-26-000133.md) | [132 d](/filings/0001517302-26-000047.md) | [94.2](/filings/0001517302-26-000091.md) | [84.6](/filings/0001517302-26-000114.md) | [110](/filings/0001517302-26-000133.md) |
| Interest expense | $m | [2.1 d](/filings/0001517302-24-000015.md) | [2.1](/filings/0001517302-24-000031.md) | [2.2](/filings/0001517302-24-000057.md) | [2.2](/filings/0001517302-25-000086.md) | [2.2 d](/filings/0001517302-26-000047.md) | [2.1](/filings/0001517302-26-000091.md) | [2.2](/filings/0001517302-26-000114.md) | [2.2](/filings/0001517302-26-000133.md) | [2.1 d](/filings/0001517302-26-000047.md) | [2.1](/filings/0001517302-26-000091.md) | [2.2](/filings/0001517302-26-000114.md) | [2.2](/filings/0001517302-26-000133.md) |
| Income tax | $m | [20.2 d](/filings/0001517302-26-000047.md) | [22.0](/filings/0001517302-25-000042.md) | [18.7](/filings/0001517302-25-000068.md) | [24.6](/filings/0001517302-25-000086.md) | [25.6 d](/filings/0001517302-26-000047.md) | [20.0](/filings/0001517302-26-000091.md) | [24.9](/filings/0001517302-26-000114.md) | [37.0](/filings/0001517302-26-000133.md) | [29.4 d](/filings/0001517302-26-000047.md) | [18.8](/filings/0001517302-26-000091.md) | [25.9](/filings/0001517302-26-000114.md) | [19.7](/filings/0001517302-26-000133.md) |
| Net income | $m | [64.8 d](/filings/0001517302-26-000047.md) | [59.5](/filings/0001517302-25-000042.md) | [57.6](/filings/0001517302-25-000068.md) | [73.0](/filings/0001517302-25-000086.md) | [69.7 d](/filings/0001517302-26-000047.md) | [61.1](/filings/0001517302-26-000091.md) | [67.6](/filings/0001517302-26-000114.md) | [66.8](/filings/0001517302-26-000133.md) | [94.8 d](/filings/0001517302-26-000047.md) | [58.0](/filings/0001517302-26-000091.md) | [80.8](/filings/0001517302-26-000114.md) | [75.2](/filings/0001517302-26-000133.md) |
| Diluted EPS | $ per share | not reported | [0.84](/filings/0001517302-25-000042.md) | [0.80](/filings/0001517302-25-000068.md) | [1.03](/filings/0001517302-25-000086.md) | not reported | [0.82](/filings/0001517302-26-000091.md) | [0.94](/filings/0001517302-26-000114.md) | [0.93](/filings/0001517302-26-000133.md) | not reported | [0.76](/filings/0001517302-26-000091.md) | [1.11](/filings/0001517302-26-000114.md) | [1.04](/filings/0001517302-26-000133.md) |
| Basic EPS | $ per share | not reported | [0.84](/filings/0001517302-25-000042.md) | [0.80](/filings/0001517302-25-000068.md) | [1.03](/filings/0001517302-25-000086.md) | not reported | [0.82](/filings/0001517302-26-000091.md) | [0.94](/filings/0001517302-26-000114.md) | [0.93](/filings/0001517302-26-000133.md) | not reported | [0.76](/filings/0001517302-26-000091.md) | [1.11](/filings/0001517302-26-000114.md) | [1.04](/filings/0001517302-26-000133.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,406](/filings/0001517302-25-000015.md) | [1,516](/filings/0001517302-24-000031.md) | [1,505](/filings/0001517302-24-000057.md) | [1,611](/filings/0001517302-24-000073.md) | [1,619](/filings/0001517302-26-000047.md) | [1,370](/filings/0001517302-25-000042.md) | [1,445](/filings/0001517302-25-000068.md) | [1,582](/filings/0001517302-25-000086.md) | [1,577](/filings/0001517302-26-000133.md) | [1,441](/filings/0001517302-26-000091.md) | [1,460](/filings/0001517302-26-000114.md) | [1,516](/filings/0001517302-26-000133.md) |
| Total liabilities | $m | [802](/filings/0001517302-25-000015.md) | [899](/filings/0001517302-24-000031.md) | [857](/filings/0001517302-24-000057.md) | [907](/filings/0001517302-24-000073.md) | [869](/filings/0001517302-26-000047.md) | [868](/filings/0001517302-25-000042.md) | [840](/filings/0001517302-25-000068.md) | [885](/filings/0001517302-25-000086.md) | [795](/filings/0001517302-26-000133.md) | [928](/filings/0001517302-26-000091.md) | [908](/filings/0001517302-26-000114.md) | [930](/filings/0001517302-26-000133.md) |
| Long-term debt | $m | [200](/filings/0001517302-25-000015.md) | [200](/filings/0001517302-24-000031.md) | [200](/filings/0001517302-24-000057.md) | [200](/filings/0001517302-24-000073.md) | [200](/filings/0001517302-26-000047.md) | [200](/filings/0001517302-25-000042.md) | [200](/filings/0001517302-25-000068.md) | [190](/filings/0001517302-25-000086.md) | [190](/filings/0001517302-26-000133.md) | [190](/filings/0001517302-26-000091.md) | [190](/filings/0001517302-26-000114.md) | [190](/filings/0001517302-26-000133.md) |
| Shareholders' equity | $m | [324](/filings/0001517302-25-000015.md) | [320](/filings/0001517302-24-000031.md) | [341](/filings/0001517302-24-000057.md) | [372](/filings/0001517302-24-000073.md) | [389](/filings/0001517302-26-000047.md) | [357](/filings/0001517302-25-000042.md) | [382](/filings/0001517302-25-000068.md) | [402](/filings/0001517302-25-000086.md) | [439](/filings/0001517302-26-000133.md) | [389](/filings/0001517302-26-000091.md) | [420](/filings/0001517302-26-000114.md) | [443](/filings/0001517302-26-000133.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.8) d](/filings/0001517302-26-000047.md) | [147](/filings/0001517302-25-000042.md) | [75.9 d](/filings/0001517302-25-000068.md) | [113 d](/filings/0001517302-25-000086.md) | [37.2 d](/filings/0001517302-26-000047.md) | [158](/filings/0001517302-26-000091.md) | [50.9 d](/filings/0001517302-26-000114.md) | [40.4 d](/filings/0001517302-26-000133.md) | [(77.3) d](/filings/0001517302-26-000047.md) | [182](/filings/0001517302-26-000091.md) | [116 d](/filings/0001517302-26-000114.md) | [110 d](/filings/0001517302-26-000133.md) |
| Capital expenditure | $m | [1.7 d](/filings/0001517302-26-000047.md) | [0.1](/filings/0001517302-25-000042.md) | [0.6 d](/filings/0001517302-25-000068.md) | [0.3 d](/filings/0001517302-25-000086.md) | [0.5 d](/filings/0001517302-26-000047.md) | [0.2](/filings/0001517302-26-000091.md) | [0.1 d](/filings/0001517302-26-000114.md) | [0.0 d](/filings/0001517302-26-000133.md) | [0.1 d](/filings/0001517302-26-000047.md) | [0.5](/filings/0001517302-26-000091.md) | [0.4 d](/filings/0001517302-26-000114.md) | [1.5 d](/filings/0001517302-26-000133.md) |
| Dividends paid | $m | [44.9 d](/filings/0001517302-26-000047.md) | [71.0](/filings/0001517302-25-000042.md) | [42.9 d](/filings/0001517302-25-000068.md) | [50.1 d](/filings/0001517302-25-000086.md) | [57.9 d](/filings/0001517302-26-000047.md) | [94.7](/filings/0001517302-26-000091.md) | [48.2 d](/filings/0001517302-26-000114.md) | [51.8 d](/filings/0001517302-26-000133.md) | [62.4 d](/filings/0001517302-26-000047.md) | [112](/filings/0001517302-26-000091.md) | [55.1 d](/filings/0001517302-26-000114.md) | [57.3 d](/filings/0001517302-26-000133.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.2](/filings/0001517302-24-000031.md) | [63.5](/filings/0001517302-24-000057.md) | [63.6](/filings/0001517302-24-000073.md) | [64.4](/filings/0001517302-25-000042.md) | [65.0](/filings/0001517302-25-000068.md) | [65.2](/filings/0001517302-25-000086.md) | [65.4](/filings/0001517302-26-000091.md) | [65.6](/filings/0001517302-26-000114.md) | [65.7](/filings/0001517302-26-000133.md) | [66.1](/filings/0001517302-26-000091.md) | [66.4](/filings/0001517302-26-000114.md) | [66.4](/filings/0001517302-26-000133.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:09 ET. No prices; not investment advice.